Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant

被引:160
|
作者
Broering, DC
Hillert, C
Krupski, G
Fischer, L
Mueller, L
Achilles, EG
Esch, JSA
Rogiers, X
机构
[1] Univ Hamburg, Hosp Eppendorf, Dept Hepatobiliary Surg, D-20246 Hamburg, Germany
[2] Univ Hamburg, Hosp Eppendorf, Dept Radiol, D-20246 Hamburg, Germany
关键词
portal vein embolization; portal vein ligation; extended liver resection; remnant liver volume;
D O I
10.1016/S1091-255X(02)00122-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The objective of this study was to assess the efficacy of right portal vein embolization (PVE) vs. right portal vein ligation (PVT) for induction of hypertrophy of the left lateral liver lobe before extended right hepatectomy. Thirty-four patients with primary or secondary liver tumors and estimated remnant functional liver parenchyma of less than 0.5% of body weight under-went either right PVE (transcutaneous, n = 10; transileocolic, n = 7) or right PVL (n = 17). Liver volume was assessed by CT scan before occlusion of the right portal vein and prior to resection. There were no deaths. The morbidity rate in each group was 5.8% (PVE, I abscess; PVL, I bile leak). The increase in liver volume was significantly higher after PVE compared with PVL (188 81 ml vs. 123 +/- 58 ml) (P = 0.012). Postoperative hospital stay was significantly shorter after PVT in comparison to PVL (4 2.9 days vs. 8.1 +/- 5.1 days; P < 0.01). Curative liver resection was performed in 10 of 17 patients after PVE and I I of 17 patients after PVL. PVT and PVL were found to be feasible and safe methods of increasing the remnant functional liver volume and achieving resectability for extended liver tumors. PVT results in a significantly more efficient increase in liver volume and a shorter hospital stay. (C) 2002 The Society for Surgery of the Alimentary Tract, Inc.
引用
收藏
页码:905 / 913
页数:9
相关论文
共 50 条
  • [21] Comparison of percutaneous transhepatic portal vein embolization and unilateral portal vein ligation
    Iida, Hiroya
    Aihara, Tsukasa
    Ikuta, Shinichi
    Yoshie, Hidenori
    Yamanaka, Naoki
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (19) : 2371 - 2376
  • [22] Comparison of percutaneous transhepatic portal vein embolization and unilateral portal vein ligation
    Hiroya Iida
    Tsukasa Aihara
    Shinichi Ikuta
    Hidenori Yoshie
    Naoki Yamanaka
    World Journal of Gastroenterology, 2012, (19) : 2371 - 2376
  • [23] Segment 4 occlusion in portal vein embolization increase future liver remnant hypertrophy - A Scandinavian cohort study
    Bjornsson, Bergthor
    Hasselgren, Kristina
    Rosok, Bard
    Larsen, Peter Noergaard
    Urdzik, Jozef
    Schultz, Nicolai A.
    Carling, Ulrik
    Fallentin, Eva
    Gilg, Stefan
    Sandstrom, Per
    Lindell, Gert
    Sparrelid, Ernesto
    INTERNATIONAL JOURNAL OF SURGERY, 2020, 75 : 60 - 65
  • [24] Increasing the remnant liver volume using portal vein embolization
    Saksirinukul, Thanis
    Kosolbhand, Permyot
    Tanpowpong, Natthaporn
    ASIAN BIOMEDICINE, 2010, 4 (05) : 817 - 820
  • [25] Multi-organ Radiomics-Based Prediction of Future Remnant Liver Hypertrophy Following Portal Vein Embolization
    Gerwing, Mirjam
    Schindler, Philipp
    Katou, Shadi
    Koehler, Michael
    Stamm, Anna Christina
    Schmidt, Vanessa Franziska
    Heindel, Walter
    Struecker, Benjamin
    Morgul, Haluk
    Pascher, Andreas
    Wildgruber, Moritz
    Masthoff, Max
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (13) : 7976 - 7985
  • [26] Multi-organ Radiomics-Based Prediction of Future Remnant Liver Hypertrophy Following Portal Vein Embolization
    Mirjam Gerwing
    Philipp Schindler
    Shadi Katou
    Michael Köhler
    Anna Christina Stamm
    Vanessa Franziska Schmidt
    Walter Heindel
    Benjamin Struecker
    Haluk Morgul
    Andreas Pascher
    Moritz Wildgruber
    Max Masthoff
    Annals of Surgical Oncology, 2023, 30 : 7976 - 7985
  • [27] Portal vein embolization: Present and future
    Piron, Lauranne
    Deshayes, Emmanuel
    Escal, Laure
    Souche, Regis
    Herrero, Astrid
    Pierredon-Foulongne, Marie-Ange
    Assenat, Eric
    Ngo le Lam
    Quenet, Francois
    Guiu, Boris
    BULLETIN DU CANCER, 2017, 104 (05) : 407 - 416
  • [28] Portal Vein Embolization: Rationale, Techniques, and Outcomes to Maximize Remnant Liver Hypertrophy with a Focus on Contemporary Strategies
    Charles, Jonathan
    Nezami, Nariman
    Loya, Mohammad
    Shube, Samuel
    Davis, Cliff
    Hoots, Glenn
    Shaikh, Jamil
    LIFE-BASEL, 2023, 13 (02):
  • [29] Future liver remnant growth after various portal vein embolization regimens: a quantitative comparison
    Biggemann, Lorenz
    Uhlig, Johannes
    Streit, Ulrike
    Sack, Henrik
    Guo, Xiao Chao
    Jung, Carlo
    Ahmed, Saheeb
    Lotz, Joachim
    Mueller-Wille, Rene
    Hosseini, Ali Seif Amir
    MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 2020, 29 (02) : 98 - 106
  • [30] Trans-Splenic Portal Vein Embolization: A Technique to Avoid Damage to the Future Liver Remnant
    Ammar Sarwar
    Olga R. Brook
    Jeffrey L. Weinstein
    Khalid Khwaja
    Muneeb Ahmed
    CardioVascular and Interventional Radiology, 2016, 39 : 1514 - 1518